RBP4 Predicts Type 2 Diabetes

Armen Hareyan's picture
Advertisement

Diabetes

A study in the June 15 issue of The New England Journal of Medicine (NEJM) reveals that elevated levels of a molecule called RBP4 (retinol binding protein 4) can foretell early stages in the development of insulin resistance, a major cause of type 2 diabetes as well as cardiovascular disease.

The new findings, led by researchers at Beth Israel Deaconess Medical Center (BIDMC), offer a potential new target for the development of anti-diabetic therapies to lower serum RBP4 levels as well as an early means of identifying individuals who are at risk of developing diabetes

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.
Advertisement